Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
Vrtala
S
S
Institute of General and Experimental Pathology, Division of Hematology, AKH, University of Vienna, Austria.
Hirtenlehner
K
K
Susani
M
M
Hufnagl
P
P
Binder
B R
BR
Vangelista
L
L
Pastore
A
A
Sperr
W R
WR
Valent
P
P
Ebner
C
C
Kraft
D
D
Valenta
R
R
D000485:Allergens / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D052179:Antigens, Plant; D003888:Desensitization, Immunologic; D005818:Genetic Engineering; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D010940:Plant Proteins / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D011058:Pollen; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*
D000485:Allergens; D052179:Antigens, Plant; D010940:Plant Proteins; D011994:Recombinant Proteins; C061312:Bet v 1 allergen, Betula